CASE REPORT
Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin
1 Department of Clinical Immunology, Royal Free Hospital, London, UK
2 Vaccine Evaluation Department, Health Protection Agency North West, Manchester, UK
3 Department of Biochemistry and Immunology, University Hospital of Wales, Cardiff, UK
Correspondence to:
Correspondence to:
S Jolles
Department of Biochemistry and Immunology, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK; stephen.jolles{at}cardiffandvale.wales.nhs.uk
The current treatment of primary antibody deficiency (PAD) is the early recognition of the condition and replacement immunoglobulin combined with prompt treatment of infections and complications. The route of administration (intravenous or subcutaneous), dose and frequency of administration of immunoglobulin still vary between centres and countries. Most infections in patients with PAD are reduced but not entirely prevented by replacement immunoglobulin, with sinopulmonary infections accounting for the bulk of the remainder. Although there have been reports of meningitis in patients with PAD before replacement treatment, we describe the first two cases of bacterial meningitis (group B Neisseria meningitidis) on adequate immunoglobulin replacement and discuss the involvement of potential cofactors.
Abbreviations: CSF, cerebrospinal fluid; MBL, mannan-binding lectin; PAD, primary antibody deficiency
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
